Latest News

Brain-imaging study links cannabinoid receptors to post-traumatic stress disorder: First pharmaceutical treatment for PTSD within reach

In a first-of-its-kind effort to illuminate the biochemical impact of trauma, researchers at NYU Langone Medical Center have discovered a connection between the quantity of cannabinoid receptors in the human brain, known as CB1 receptors, and post-traumatic stress disorder, the chronic, disabling condition that can plague trauma victims with flashbacks, nightmares and emotional instability.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • New therapeutic target may improve treatment for brain cancer

  • New compounds could offer therapy for multitude of diseases

  • Stem cells make similar decisions to humans

  • Why good solutions make us oblivious to better ones

  • When attention is a deficit: Sometimes a new strategy makes sense

  • Stereotypes lower math performance in women, but effects go unrecognized

  • For drivers with telescopic lenses, driving experience and training affect road test results

  • Will you ever pay off your student loan?

  • Public Health Responsibility Deal in UK unlikely to be an effective response to alcohol harms

  • Immunotherapy used to reduce memory problems with Alzheimer's disease

  •